ROR1 expressed in chronic lymphocytic leukemia (CLL) can also serve as a receptor for Wnt5a, which induces ROR1 to associate with DOCK2 (dedicator of cytokinesis 2) and induces activation of Rac1/2 [60]. Here, DOCK2 is linked to B-cell chronic lymphocytic leukemia.